Novo Nordisk stock surged Friday after the obesity kingpin reported strong results for its next-generation weight-loss drug, amycretin.
Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight ...
On Friday, however, Novo Nordisk announced top-line results in yet another trial. While the results don't initially sound as ...
Key Takeaways Allurion Technologies said it planned to test its gastric balloon with the key ingredient in popular ...
Mimi Davenport, a women's fitness coach, has shared how you can make a plate of avocado on toast with a side of eggs ...
Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin ...
Although this study focused on elderberry juice specifically, elderberry supplements are also widely available in the U.S. Chromium picolinate is another supplement that may aid in weight loss.
A novel GLP-1 and amylin receptor agonist featured a safety profile similar to other incretin-based therapies and conferred a ...
The ex glamour model, 46, took to her Instagram Stories from her hospital bed  on Friday and said she was 'nice and calm' moments before being wheeled to surgery ...
Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...
Amycretin could give Novo a buzzy product in an newly competitive obesity market. It works similarly to existing GLP-1 ...
The ‘Full House’ star was diagnosed with stage 3 non-Hodgkin lymphoma in October 2024 Even as much of the country is ...